• Publications
  • Influence
The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population
The Brief Repeatable Battery of Neuropsychological Tests (BRB) is by far the most widely used instrument to estimate cognitive dysfunction in multiple sclerosis (MS) patients. However, the paucity ofExpand
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis
This study evaluated rates of adherence to prescribed treatment and explored factors affecting adherence amongst patients with relapsing‐remitting MS. Expand
The prevalence of pain in multiple sclerosis
Comparison between different groups showed significant differences for age, Expanded Disability Status Scale, disease duration, and disease course, but not for sex, underlines the relevance of pain in the clinical history of MS. Expand
Cognitive and psychosocial features of childhood and juvenile MS
In childhood and juvenile cases, multiple sclerosis is associated with cognitive impairment and low IQ scores, the latter related to younger age at onset, which is of critical importance in helping children and adolescents with MS to manage their difficulties and psychosocial challenges. Expand
The impact of outpatient rehabilitation on quality of life in multiple sclerosis
The results of this study confirm the effectiveness of a short comprehensive outpatient model of rehabilitative treatment in people with MS and in particular in their QoL. Expand
The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis
DYMUS demonstrated to be an easy and consistent tool to detect dysphagia and its main characteristics in MS and can be used for preliminary selection of patients to submit to more specific instrumental analyses, and to direct toward programs for prevention of aspiration. Expand
Caregiver quality of life in multiple sclerosis: a multicentre Italian study
Caregiving was associated with lower mental health, vitality and general health scores, compared to healthy subjects, and supportive strategies for MS caregivers are warranted. Expand
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled,
A phase 3, randomised, double-blind, placebo-controlled, multicentre study in 76 hospitals and specialised clinics across North America, Latin America, Europe, and Asia to assess the efficacy and safety of eculizumab in patients with refractory myasthenia gravis. Expand
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people with multiple sclerosis (PwMS).
Cognitive and psychosocial features in childhood and juvenile MS
The findings confirm the importance of systematic assessment of cognitive and psychosocial issues in children and teens with MS and the progressive nature of the cognitive difficulties emphasizes the need for developing effective treatment strategies. Expand